EQ compared with PRQR: revenue, margins and what each company keeps, and the suppliers and customers both name

EQEquillium, Inc.

Mkt capRevenueRevenue

PRQRProQR Therapeutics N.V.

Mkt capRevenueRevenue

Compare

EQEquillium, Inc.

PRQRProQR Therapeutics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

EQ, solidPRQR, dashed

Supply-chain overlap

Revenue flow

EQ: latest quarter is a loss; flow not drawable. PRQR: latest quarter not drawable.Method ›

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

PRQRProQR Therapeutics N.V.

1.38▼−4.31%· post 1.43

ClosedOct 30 '26

Mkt cap$146.5MRevenue—Revenue—

Compare

ClosedOct 30 '26

EQEquillium, Inc.

PRQRProQR Therapeutics N.V.

1.38▼−2.90%post 1.38

Price

1.38▼−4.31%post 1.43

$86.9M

Mkt cap

$146.5M

Q4 FY24$4M

Revenue

—

FY24$41M

Revenue

—

EQ1.38▼−2.90%vsPRQR1.38▼−4.31%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Shared 0

No shared counterparties.

Only PRQR 1

LLYEli Lillycustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR